The mechanistic basis of infarct healing

被引:216
作者
Frangogiannis, Nikolaos G. [1 ]
机构
[1] Baylor Coll Med, Sect Cardiovasc Sci, Houston, TX 77030 USA
关键词
D O I
10.1089/ars.2006.8.1907
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myocardial infarction triggers an inflammatory cascade that results in healing and replacement of the damaged tissue with scar. Cardiomyocyte necrosis triggers innate immune mechanisms eliciting Toll-like receptor-mediated responses, activating the complement cascade and generating reactive oxygen species. Subsequent activation of NF-kappa B is a critical element in the regulation of cytokine, chemokine, and adhesion molecule expression in the ischemic myocardium. Chemokine induction mediates leukocyte recruitment in the myocardium. Pleiotropic proinflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, are also upregulated in the infarct and exert a wide range of effects on a variety of cell types. Timely repression of proinflammatory gene synthesis is crucial for optimal healing; IL-10 and TGF-beta-mediated pathways may be important for suppression of chemokine and cytokine expression and for resolution of the leukocytic infiltrate. In addition, TGF-beta may be critically involved in inducing myofibroblast differentiation and activation, promoting extracellular matrix protein deposition in the infarcted area. The composition of the extracellular matrix plays an important role in regulating cell behavior. Both structural and matricellular proteins modulate cell signaling through interactions with specific surface receptors. The molecular and cellular changes associated with infarct healing directly influence ventricular remodeling and affect prognosis in patients with myocardial infarction.
引用
收藏
页码:1907 / 1939
页数:33
相关论文
共 396 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   ADHESION MOLECULES AND INFLAMMATORY INJURY [J].
ALBELDA, SM ;
SMITH, CW ;
WARD, PA .
FASEB JOURNAL, 1994, 8 (08) :504-512
[3]   CONSTITUTIVE OVEREXPRESSION OF A GROWTH-REGULATED GENE IN TRANSFORMED CHINESE-HAMSTER AND HUMAN-CELLS [J].
ANISOWICZ, A ;
BARDWELL, L ;
SAGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7188-7192
[4]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[5]   Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat [J].
Aoyama, T ;
Takimoto, Y ;
Pennica, D ;
Inoue, R ;
Shinoda, E ;
Hattori, R ;
Yui, Y ;
Sasayama, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (10) :1821-1830
[6]   An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion [J].
Arai, M ;
Lefer, DJ ;
So, T ;
DiPaula, A ;
Aversano, T ;
Becker, LC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) :1278-1285
[7]   ROLE OF H1 RECEPTORS AND P-SELECTIN IN HISTAMINE-INDUCED LEUKOCYTE ROLLING AND ADHESION IN POSTCAPILLARY VENULES [J].
ASAKO, H ;
KUROSE, I ;
WOLF, R ;
DEFREES, S ;
ZHENG, ZL ;
PHILLIPS, ML ;
PAULSON, JC ;
GRANGER, DN .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1508-1515
[8]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[9]   Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy [J].
Askari, AT ;
Unzek, S ;
Popovic, ZB ;
Goldman, CK ;
Forudi, F ;
Kiedrowski, M ;
Rovner, A ;
Ellis, SG ;
Thomas, JD ;
DiCorleto, PE ;
Topol, EJ ;
Penn, MS .
LANCET, 2003, 362 (9385) :697-703
[10]   A CHIMERIC IGG4 MONOCLONAL-ANTIBODY DIRECTED AGAINST CD18 REDUCES INFARCT SIZE IN A PRIMATE MODEL OF MYOCARDIAL-ISCHEMIA AND REPERFUSION [J].
AVERSANO, T ;
ZHOU, W ;
NEDELMAN, M ;
NAKADA, M ;
WEISMAN, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :781-788